Versarien extends deal with Montana Quimica.


Versarien announced the extension of its existing commercial agreements with Montana Química on Friday, to broaden the use of its proprietary ‘Polygrene’ thermoplastic compounds in South America.

  • Versarien
  • 04 July 2025 12:28:22
Versarien

Source: Sharecast

The AIM-traded advanced materials group said the expanded agreements covered additional manufacturing rights, technical assistance, and training related to its graphene-enhanced products.

Under the revised terms, Montana would pay Versarien £25,000 for the provision of further know-how and support, with an additional £25,000 payable once manufacturing starts.

Versarien said it would also receive a 5% royalty on sales of any products made using its intellectual property, subject to a minimum annual royalty of £10,000.

The payments would be in addition to those already outlined in agreements signed in March 2024 and March 2025.

“We are very pleased to be extending our partnership with Montana, a leading business in its markets in South America that we have developed a close relationship with,” said Dr Stephen Hodge, CEO of Versarien.

“We look forward to supporting Montana and its clients as they bring added-value products to the market utilising Polygrene thermoplastics.”

At 1202 BST, shares in Versarien were up 25.39% at 0.02p.

Reporting by Josh White for Sharecast.com.


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.